rxstat › Shortages › Medronic Acid

Medronic Acid (Stannous Mdp, Draximage Mdp-25) shortage status

Widespread shortage Tier 3: critical

Source: Health Canada shortage reports · Updated Aug 10, 2026

Also sold as: Stannous Mdp, Draximage Mdp-25, Draximage Mdp

Medronic Acid is in a widespread shortage in Canada. 3 of 3 reported products are affected, and Health Canada has designated this a Tier 3 (most serious) shortage. The latest manufacturer estimate for full recovery is Nov 30, 2026.
Products affected
3 / 3
In shortage since
May 27, 2026
Est. full return
Nov 30, 2026
Reports on file
4
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
DRAXIMAGE MDP-25
25MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
DIN 02329239 · since May 27, 2026, est. end Nov 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
DRAXIMAGE MDP
10MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
DIN 02329409 · since Jun 3, 2026, est. end Sep 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
STANNOUS MDP KIT
15MG · KIT SOLUTION · CALGARY RADIOPHARMACEUTICAL CENTRE / ALBERTA HEALTH SERVICES
DIN 02485834 · since Jul 23, 2026, est. end Sep 23, 2026 · Shortage of an inactive ingredient or component.
Resolved
DRAXIMAGE MDP-25
25MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
DIN 02329239 · ended Dec 21, 2022

What's happening

Medronic Acid is currently affected by 3 active shortage reports filed with Health Canada by JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA, CALGARY RADIOPHARMACEUTICAL CENTRE / ALBERTA HEALTH SERVICES.

The reported causes are: disruption of the manufacture of the drug; shortage of an inactive ingredient or component. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

Health Canada has flagged this as a Tier 3 shortage, its most serious category, meaning the shortage has the greatest potential impact on the health system and alternatives are limited.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

When will Medronic Acid be back in stock in Canada?

The latest manufacturer estimate is Nov 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Medronic Acid in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Tetrasodium Pyrophosphate (Stannous Pyp) Widespread shortage 2 of 2 reported products affected · est. return Mar 31, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.